Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension

References

• American Heart AssociationHeart Disease and Stroke Statistics – 2008 UpdateDallas, TexasAmerican Heart Association2008
   Google Scholar
• MathersCBoermaTFatDMfor WHO staffThe global burden of disease: 2004 updateAccessed Nov 2008. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf
   Google Scholar
• YusufSSleightPPogueJBoschJDaviesRDagenaisGEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342314515310639539
   PubMed Web of Science ®Google Scholar
• SleightPYusufSPogueJTsuyukiRBlood-pressure reduction and cardiovascular risk in HOPE studyLancet200135892992130213111784631
   PubMed Web of Science ®Google Scholar
• SvenssonPde FaireUSleightPComparative effects of ramipril on ambulatory and office blood pressures; A HOPE SubstudyHypertension200038e28e3211751742
   PubMedGoogle Scholar
• FreemantleNClelandJYoungPBeta blockade after myocardial infarction: systematic review and meta regression analysisBMJ19993181730173710381708
   PubMed Web of Science ®Google Scholar
• EllisonKEGandhiGOptimizing the use of β-adrenoceptor antagonists in coronary artery diseaseDrugs200565678779715819591
   PubMed Web of Science ®Google Scholar
• AntmanEMHandMArmstrongPW2007Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing CommitteeCirculation200811729632918071078
   PubMed Web of Science ®Google Scholar
• KennedyHBeta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT and EMIATAm J Cardiol1997809120812119359552
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRSeventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension2003421206125214656957
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakAThe 2007 Guidelines for the Management of Arterial HypertensionEur Heart J2007281462153617562668
   PubMed Web of Science ®Google Scholar
• LindholmLHCarlbergBSamuelssonOShould beta blockers remain first choice in the treatment of primary hypertension? A meta-analysisLancet200536694961545155316257341
   PubMed Web of Science ®Google Scholar
• KhanNMcAlisterFARe-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysisCMAJ2006174121737174216754904
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA20022882981299712479763
   PubMed Web of Science ®Google Scholar
• RosendorffCBlackHRCannonCPAHA Scientific Statement: Treatment of hypertension in the prevention and management of ischemic heart diseaseCirculation20071152761278817502569
   PubMed Web of Science ®Google Scholar
• CroomKFWellingtonKModified-Release Nifedipine: A Review of the use of modified-release formulations in the treatment of hypertension and angina pectorisDrugs200666449752816597165
   PubMed Web of Science ®Google Scholar
• SorkinEMClissoldSPBrogdenRNNifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ischaemic heart disease, hypertension, and related cardiovascular disordersDrugs1985301822742412780
   PubMed Web of Science ®Google Scholar
• GrundyJSFosterRTThe nifedipine gastrointestinal therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological propertiesClin Pharmacokinet199630128518846626
   PubMed Web of Science ®Google Scholar
• HeagertyAMNifedipine gastrointestinal therapeutic system – hypertension management to improve cardiovascular outcomesInt J Clin Pract20055991112111916115193
   PubMedGoogle Scholar
• ManciniGBAntiatherosclerotic effects of calcium channel blockersProg Cardiovasc Dis20024512012138411
   PubMed Web of Science ®Google Scholar
• ManciniGBMillerMEEvansGWfor PREVENT Study GroupPost hoc analysis of coronary findings from the Prospective Randomized Evaluation of the Vascular Effects of the Norvasc Trial (PREVENT)Am J Cardiol2002891414141612062738
   PubMed Web of Science ®Google Scholar
• SimonAGariepyJMoyseDDifferential effects of nifedipine and co-amilozide on the progression of early carotid wall changesCirculation20011032949295411413085
   PubMed Web of Science ®Google Scholar
• PittBByingtonRPFurbergCDEffect of amlodipine on the progression of atherosclerosis and the occurrence of clinical eventsCirculation20001021503151011004140
   PubMed Web of Science ®Google Scholar
• ZanchettiABondMGHeningMCalcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosisCirculation20021062422242712417537
   PubMed Web of Science ®Google Scholar
• PsatyBMHeckbertSRKoepsellTDThe risk of myocardial infarction associated with antihypertensive drug therapiesJAMA19952746206257637142
   PubMed Web of Science ®Google Scholar
• FurbergCDPsatyBMMeyerJVNifedipine: Dose-related increase in mortality in patients with coronary heart diseaseCirculation199592132613317648682
   PubMed Web of Science ®Google Scholar
• RafflenbeulWNifedipine in acute coronary syndromes: Furberg’s refrain revisitedEur Heart J199617114711528869854
   PubMed Web of Science ®Google Scholar
• TijssenJGPHugenholtzPGCritical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertensionEur Heart J199617115211578869855
   PubMed Web of Science ®Google Scholar
• GongLZhangWZhuYShanghai Trial of Nifedipine in the Elderly (STONE)J Hypertens19961410123712458906524
   PubMed Web of Science ®Google Scholar
• WuYKEpidemiology and the community control of hypertension, stroke, and coronary heart disease in ChinaChinese Med J197992665670
   PubMed Web of Science ®Google Scholar
• YuiYSumiyoshiTKodamaKComparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan multicenter investigation for cardiovascular diseases-B (JMIC-B) randomized trialHypertens Res200427318119115080377
   PubMed Web of Science ®Google Scholar
• PristipinoCBeltrameJFinocchiaroMLMajor racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarctionCirculation20001011102110810715255
   PubMed Web of Science ®Google Scholar
• Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension: Guidelines for the management of hypertension for general practitionersHypertens Res20012461363411768720
   PubMed Web of Science ®Google Scholar
• YoshitoshiYKanekoYSarutaTAntihypertensive effect of MK-421 (enalapril maleate) with concomitant thiazide diuretics in patients with essential hypertension: multiclinic pilot, open studyJpn Pharmacol Ther19841234393468
   Google Scholar
• SarutaTOmaeTIimuraOEfficacy and safety of imidapril (ACE/TA-6366), angiotensin I converting enzyme inhibitor, in monotherapy on essential hypertension multiclinic open studyRinsho Igaku1991724852504
   Google Scholar
• ArakawaKIimuraOYoshinagaKAntihypertensive effect of lisinopril (MK-521) in essential hypertension: result of a multiclinic open trialSaishin Igaku199045834858
   Google Scholar
• Clinical Evaluation of Antihypertensive Drugs GroupProposed guidelines for the clinical evaluation of antihypertensive drugsDrug Res197910849864
   Google Scholar
• ShinodaEYoshikiYKodamaKQuantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B Side Arm Study)Hyertension20054511531158
   PubMed Web of Science ®Google Scholar
• BrownMJPalmerCRCastaigneAMorbidity and mortality in patients randomized to double-blind treatment with long-acting calcium-channel blocker or diuretic in the international nifedipine GITS Study: intervention as a goal in hypertension treatment (INSIGHT)Lancet200035636637210972368
   PubMed Web of Science ®Google Scholar
• MotroMShemeshJCalcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diureticsHypertension2001371410141311408386
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPALubsenJKirwanBAEffect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trialLancet200436484985715351192
   PubMed Web of Science ®Google Scholar
• PittBByingtonRPFurbergCDEffect of amlodipine on the progression of atherosclerosis and the occurrence of clinical eventsCirculation2000102131503151011004140
   PubMed Web of Science ®Google Scholar
• OzakiYKeaneDSerruysPWProgression and regression of coronary stenosis in the long-term follow-up of vasospastic anginaCirculation199592244624567586344
   PubMed Web of Science ®Google Scholar
• DensJADesmetWJCoussementPLong term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE studyHeart20038988789212860866
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMLibbyPEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomized controlled trialJAMA20042922217222615536108
   PubMed Web of Science ®Google Scholar
• TattiPPahorMByingtonRPOutcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDMDiabetes Care19982145976039571349
   PubMed Web of Science ®Google Scholar
• FortiniACappellettiCCecchiLLaureanoRFosinopril in the treatment of hypertension: effects on 24 h ambulatory blood pressure and on blood pressure response to exerciseJ Hum Hypertens199484694748089833
   PubMed Web of Science ®Google Scholar
• BainbridgeADHerlihyOMeredithPAElliottHLA comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indicesEur J Clin Pharmacol1993454254308112371
   PubMed Web of Science ®Google Scholar
• KirkendallWMComparative assessment of first-line agents for treatment of hypertensionAm J Med198884Suppl 3B32413260071
   PubMedGoogle Scholar
• WeinsteinDBHeiderJGAntiatherogenic properties of calcium antagonistsAm J Cardiol198759163B172B2949576
   PubMed Web of Science ®Google Scholar
• ChobanianAVEffects of calcium antagonists and other antihypertensive drugs on atherosclerosisJ Hypertens Suppl19875Suppl 44348
   Google Scholar
• WeinsteinDBHeiderJGProtective action of calcium antagonists in atherosclerosis and experimental vascular injuryAm J Hypertens198922052122645920
   PubMed Web of Science ®Google Scholar
• BondMGPurvisCMercuriMAntiatherogenic properties of calcium antagonistsJ Cardiovasc Pharmacol199117Suppl 48793
   Google Scholar
• BorhaniNoMercuriMBorhaniPAFinal outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS): A randomized controlled trialJAMA1996276107857918769587
   PubMed Web of Science ®Google Scholar
• FurbergCDByingtonRPBorhaniNODesign features: multicenter isradipine diuretic atherosclerosis Study (MIDAS)Am J Med198986Suppl 4A37392523653
   PubMed Web of Science ®Google Scholar
• BorhaniNOBondMGSowersJRThe MIDAS: a study of the antiatherogenic properties of isradipine in hypertensive patientsJ Cardiovasc Pharmacol199118Suppl 31519
   Google Scholar
• HanssonLLindholmLHEkbomTRandomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study (STOP-2)Lancet19993541751175610577635
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomized controlled trialThe Lancet20053669489895906
   PubMed Web of Science ®Google Scholar
• StaessenJAFagardEThijsLRandomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionLancet19973507577649297994
   PubMed Web of Science ®Google Scholar
• National Intervention Cooperative Study in Elderly Hypertensives Study GroupRandomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensivesHypertension1999341129113310567194
   PubMed Web of Science ®Google Scholar
• DahlofALindholmLHHanssonLMorbidity and mortality in the Swedish trial in old Patients with hypertension (STOP-Hypertension)Lancet1991338128112851682683
   PubMed Web of Science ®Google Scholar
• SavagePJPresselSLCurbJDfor the SHEP Cooperative Research GroupInfluence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly ProgramArch Intern Med19981587417519554680
   PubMed Web of Science ®Google Scholar
• MRC Working PartyMedical Research Council trial of treatment of hypertension in older adults: principal resultsBMJ19923044054121445513
   PubMed Web of Science ®Google Scholar
• LiuLWangGGongLLiuGStaessenJAComparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJ Hypertens199816182318299869017
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med2008359232417242819052124
   PubMed Web of Science ®Google Scholar
• ChobanianAVDoes It Matter How Hypertension Is Controlled?N Engl J Med2008359232485248719052130
   PubMed Web of Science ®Google Scholar
• HosodaSIinoTYasudaHLong-term follow-up of medically treated patients with coronary artery disease: incidence of major cardiac events and its risk factors in Japanese with coronary artery diseaseJpn Circ J1990542312402195178
   PubMedGoogle Scholar